Last Chance Pd 153035 Hydrochloride 40% Off - Today Only [WisyvDF8]

Last Chance Pd 153035 Hydrochloride 40% Off - Today Only [WisyvDF8]: A Versatile Research Tool

Last Chance Pd 153035 Hydrochloride 40% Off - Today Only [WisyvDF8] is a highly regarded research compound with a wide range of applications across various scientific disciplines. This compound is renowned for its ability to selectively inhibit certain receptor tyrosine kinases, making it an invaluable asset in cancer research. Its unique properties allow scientists to delve into the mechanisms of tumor growth and progression, offering new insights into the treatment and prevention of various cancer types.

Technical Specifications and Properties

Last Chance Pd 153035 Hydrochloride 40% Off - Today Only [WisyvDF8] boasts several key properties that make it an ideal choice for research. This compound is highly pure and stable, ensuring consistent and reliable results across experiments. It is also readily soluble in water, which simplifies the preparation process and enhances its versatility. With a molecular weight of 612.96 g/mol and a CAS number of 130437-90-7, Last Chance Pd 153035 Hydrochloride 40% Off - Today Only [WisyvDF8] is a well-characterized compound that meets the highest standards of research quality.

Applications and Benefits

Last Chance Pd 153035 Hydrochloride 40% Off - Today Only [WisyvDF8] finds extensive use in a variety of research fields, including cancer research, neuroscience, pharmacology, cell biology, and biotechnology. Its selective inhibition of receptor tyrosine kinases makes it particularly useful in studying tumor growth and progression, while its role in neuroscience research aids in understanding neurodegenerative diseases. Additionally, its potential as a therapeutic agent in pharmacology and its ability to elucidate cell signaling mechanisms in cell biology are significant contributions to scientific advancements. By using Last Chance Pd 153035 Hydrochloride 40% Off - Today Only [WisyvDF8], researchers can develop targeted therapies with fewer side effects, paving the way for more effective treatments in the medical field.